U.S. Physical Therapy Toekomstige groei
Future criteriumcontroles 3/6
De verwachting is dat U.S. Physical Therapy de winst en omzet met respectievelijk 47.5% en 7.3% per jaar zal laten groeien, terwijl de winst per aandeel naar verwachting zal groeien met 52.4% per jaar.
Belangrijke informatie
47.5%
Groei van de winst
52.36%
Groei van de winst per aandeel
| Healthcare winstgroei | 19.1% |
| Inkomstengroei | 7.3% |
| Toekomstig rendement op eigen vermogen | n/a |
| Dekking van analisten | Good |
| Laatst bijgewerkt | 21 May 2026 |
Recente toekomstige groei-updates
Recent updates
Narratiefupdate • May 30
USPH: Hospital Alliances And Medicare Pricing Will Drive Future Margin Recovery
Analysts have trimmed their blended price target on U.S. Physical Therapy from about $107 to roughly $94, reflecting lower P/E assumptions and somewhat softer profitability expectations, along with higher net debt. They also note potential margin improvement supported by hospital alliances and improved Medicare rates.Seeking Alpha • May 22
U.S. Physical Therapy: The Valuation Reset Changes The Story (Rating Upgrade)
Summary U.S. Physical Therapy, Inc. has seen valuation multiples compress significantly despite continued revenue growth and new strategic initiatives. U.S. Physical Therapy reported Q1 2026 revenue of $198.3M (+7.9% YoY) but missed EPS expectations due to higher costs from acquisitions and clinic startups. Management is pursuing hospital partnerships and shifting toward private insurance, aiming to boost clinic utilization and reduce reliance on Medicare/Medicaid. I now rate U.S. Physical Therapy as hold, reflecting improved risk/reward at current valuation but acknowledging persistent structural challenges and margin pressures. Read the full article on Seeking AlphaAnalyseartikel • Sep 12
These 4 Measures Indicate That U.S. Physical Therapy (NYSE:USPH) Is Using Debt Reasonably Well
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...Analyseartikel • Aug 02
Pinning Down U.S. Physical Therapy, Inc.'s (NYSE:USPH) P/E Is Difficult Right Now
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 17x, you may...Analyseartikel • Jul 11
U.S. Physical Therapy (NYSE:USPH) Is Reinvesting At Lower Rates Of Return
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a...Analyseartikel • Jun 10
Here's Why U.S. Physical Therapy (NYSE:USPH) Can Manage Its Debt Responsibly
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...Analyseartikel • May 14
Here's Why It's Unlikely That U.S. Physical Therapy, Inc.'s (NYSE:USPH) CEO Will See A Pay Rise This Year
Key Insights U.S. Physical Therapy's Annual General Meeting to take place on 20th of May CEO Chris Reading's total...Analyseartikel • Mar 24
Should You Think About Buying U.S. Physical Therapy, Inc. (NYSE:USPH) Now?
U.S. Physical Therapy, Inc. ( NYSE:USPH ), might not be a large cap stock, but it received a lot of attention from a...Analyseartikel • Mar 01
U.S. Physical Therapy, Inc. Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next
Last week, you might have seen that U.S. Physical Therapy, Inc. ( NYSE:USPH ) released its yearly result to the market...Analyseartikel • Feb 28
U.S. Physical Therapy (NYSE:USPH) Seems To Use Debt Quite Sensibly
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...Analyseartikel • Jan 03
Capital Allocation Trends At U.S. Physical Therapy (NYSE:USPH) Aren't Ideal
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. In a perfect...Analyseartikel • Nov 09
Shareholders Should Be Pleased With U.S. Physical Therapy, Inc.'s (NYSE:USPH) Price
When close to half the companies in the Healthcare industry in the United States have price-to-sales ratios (or "P/S...
Nieuw narratief • Sep 14
Tactical Contract Renegotiations And Innovative Recruitment Tactics Propel Revenue Growth And Margin Expansion
Innovations in recruitment and operational efficiencies are set to bolster net margins despite a tight labor market and high costs.Analyseartikel • Aug 07
U.S. Physical Therapy (NYSE:USPH) Might Be Having Difficulty Using Its Capital Effectively
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'll...Analyseartikel • Jul 17
U.S. Physical Therapy (NYSE:USPH) Has A Rock Solid Balance Sheet
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Analyseartikel • Jun 04
U.S. Physical Therapy, Inc.'s (NYSE:USPH) Business Is Trailing The Industry But Its Shares Aren't
When you see that almost half of the companies in the Healthcare industry in the United States have price-to-sales...Analyseartikel • May 21
There May Be Reason For Hope In U.S. Physical Therapy's (NYSE:USPH) Disappointing Earnings
The market for U.S. Physical Therapy, Inc.'s ( NYSE:USPH ) shares didn't move much after it posted weak earnings...Analyseartikel • May 11
U.S. Physical Therapy (NYSE:USPH) Is Due To Pay A Dividend Of $0.44
The board of U.S. Physical Therapy, Inc. ( NYSE:USPH ) has announced that it will pay a dividend of $0.44 per share on...Analyseartikel • May 05
Returns On Capital Signal Tricky Times Ahead For U.S. Physical Therapy (NYSE:USPH)
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Analyseartikel • Apr 21
A Look At The Fair Value Of U.S. Physical Therapy, Inc. (NYSE:USPH)
Key Insights Using the 2 Stage Free Cash Flow to Equity, U.S. Physical Therapy fair value estimate is US$113 U.S...Analyseartikel • Apr 07
Is Now The Time To Look At Buying U.S. Physical Therapy, Inc. (NYSE:USPH)?
While U.S. Physical Therapy, Inc. ( NYSE:USPH ) might not have the largest market cap around , it saw a decent share...Analyseartikel • Mar 04
U.S. Physical Therapy, Inc.'s (NYSE:USPH) Shareholders Might Be Looking For Exit
When you see that almost half of the companies in the Healthcare industry in the United States have price-to-sales...Analyseartikel • Dec 23
The Returns On Capital At U.S. Physical Therapy (NYSE:USPH) Don't Inspire Confidence
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a...Analyseartikel • Dec 07
Why U.S. Physical Therapy, Inc. (NYSE:USPH) Could Be Worth Watching
While U.S. Physical Therapy, Inc. ( NYSE:USPH ) might not be the most widely known stock at the moment, it saw a...Seeking Alpha • Oct 13
U.S. Physical Therapy: Positioned For Market Dominance Amidst Attractive Valuations
Summary USPH has a substantial presence in the physical therapy industry, with 662 clinics in 41 states, particularly Texas and Tennessee. Acquisitions, primarily through partnership models, are central to USPH's growth strategy. The company expanded into the IIP sector in 2017 and has made several acquisitions. The U.S. rehab market is projected to exceed $40 billion by 2025, driven by demographic trends like an aging population, rising obesity, and a focus on cost-effective healthcare. Physical therapy has demonstratedcost-effectiveness in patient care, significantly reducing hospitalization ratesand total treatment costs. USPH's current stock valuepresents a favorable entry point, especially with market misconceptions aboutGLP-1 adoption impacting the physical therapy industry. Read the full article on Seeking AlphaWinst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2028 | 981 | 56 | N/A | N/A | 1 |
| 12/31/2027 | 896 | 72 | 83 | 108 | 7 |
| 12/31/2026 | 839 | 57 | 68 | 92 | 7 |
| 3/31/2026 | 788 | 8 | 67 | 84 | N/A |
| 12/31/2025 | 773 | 22 | 61 | 75 | N/A |
| 9/30/2025 | 751 | 36 | 57 | 70 | N/A |
| 6/30/2025 | 722 | 35 | 61 | 72 | N/A |
| 3/31/2025 | 692 | 33 | 56 | 66 | N/A |
| 12/31/2024 | 664 | 28 | 66 | 75 | N/A |
| 9/30/2024 | 639 | 14 | 73 | 82 | N/A |
| 6/30/2024 | 621 | 16 | 68 | 77 | N/A |
| 3/31/2024 | 606 | 18 | 66 | 75 | N/A |
| 12/31/2023 | 599 | 18 | 73 | 82 | N/A |
| 9/30/2023 | 585 | 24 | 64 | 72 | N/A |
| 6/30/2023 | 575 | 26 | 62 | 70 | N/A |
| 3/31/2023 | 564 | 28 | 50 | 58 | N/A |
| 12/31/2022 | 548 | 29 | 50 | 59 | N/A |
| 9/30/2022 | 536 | 39 | 48 | 57 | N/A |
| 6/30/2022 | 522 | 38 | 59 | 68 | N/A |
| 3/31/2022 | 509 | 37 | 61 | 70 | N/A |
| 12/31/2021 | 490 | 31 | 68 | 76 | N/A |
| 9/30/2021 | 477 | 31 | 78 | 86 | N/A |
| 6/30/2021 | 461 | 30 | 81 | 87 | N/A |
| 3/31/2021 | 418 | 32 | 95 | 101 | N/A |
| 12/31/2020 | 418 | 32 | 92 | 100 | N/A |
| 9/30/2020 | 423 | 30 | 82 | 91 | N/A |
| 6/30/2020 | 431 | 31 | 72 | 82 | N/A |
| 3/31/2020 | 473 | 29 | 55 | 65 | N/A |
| 12/31/2019 | 477 | 31 | N/A | 62 | N/A |
| 9/30/2019 | 472 | 30 | N/A | 65 | N/A |
| 6/30/2019 | 468 | 23 | N/A | 71 | N/A |
| 3/31/2019 | 457 | 18 | N/A | 71 | N/A |
| 12/31/2018 | 449 | 17 | N/A | 73 | N/A |
| 9/30/2018 | 442 | 18 | N/A | 70 | N/A |
| 6/30/2018 | 432 | 22 | N/A | 65 | N/A |
| 3/31/2018 | 421 | 21 | N/A | 58 | N/A |
| 12/31/2017 | 410 | 22 | N/A | 57 | N/A |
| 9/30/2017 | 392 | 20 | N/A | 53 | N/A |
| 6/30/2017 | 377 | 20 | N/A | 42 | N/A |
| 3/31/2017 | 363 | 21 | N/A | 51 | N/A |
| 12/31/2016 | 353 | 21 | N/A | 51 | N/A |
| 9/30/2016 | 348 | 20 | N/A | 48 | N/A |
| 6/30/2016 | 344 | 21 | N/A | 49 | N/A |
| 3/31/2016 | 337 | 21 | N/A | 49 | N/A |
| 12/31/2015 | 327 | 21 | N/A | 38 | N/A |
| 9/30/2015 | 320 | 21 | N/A | 45 | N/A |
| 6/30/2015 | 313 | 20 | N/A | 43 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei USPH ( 47.5% per jaar) ligt boven de spaarquote ( 3.5% ).
Winst versus markt: De winst van USPH ( 47.5% per jaar) zal naar verwachting sneller groeien dan de US markt ( 17.9% per jaar).
Hoge groeiwinsten: De winst van USPH zal naar verwachting de komende 3 jaar aanzienlijk groeien.
Omzet versus markt: De omzet van USPH ( 7.3% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 12.5% per jaar).
Hoge groei-inkomsten: De omzet van USPH ( 7.3% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van USPH naar verwachting over 3 jaar hoog zal zijn
Ontdek groeibedrijven
Bedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/06/11 21:31 |
| Aandelenkoers aan het einde van de dag | 2026/06/11 00:00 |
| Inkomsten | 2026/03/31 |
| Jaarlijkse inkomsten | 2025/12/31 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysemodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen over hoe je onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
U.S. Physical Therapy, Inc. wordt gevolgd door 15 analisten. 7 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| Michael Petusky | Barrington Research Associates, Inc. |
| Joanna Sylvia Gajuk | BofA Global Research |
| Joseph France | Cantor Fitzgerald & Co. |